Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy.

Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, Zhang Z, Kepp O, Kroemer G.

J Immunother Cancer. 2020 Mar;8(1). pii: e000462. doi: 10.1136/jitc-2019-000462.

2.

Mammary analogue secretory carcinoma: An Indian experience of a novel entity.

Nisar Z, Pol JN, Jagdale RV, Phadke MD, Kadkol GA.

Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S134-S140. doi: 10.4103/IJPM.IJPM_757_18.

3.

Recovery of cognitive function after relapse in multiple sclerosis.

Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B.

Mult Scler. 2020 Jan 23:1352458519898108. doi: 10.1177/1352458519898108. [Epub ahead of print]

PMID:
31971066
4.

Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer.

van de Pol JAA, van den Brandt PA, van Engeland M, Godschalk RWL, van Schooten FJ, Hogervorst JGF, Schouten LJ.

Sci Rep. 2020 Jan 10;10(1):137. doi: 10.1038/s41598-019-56980-0.

5.

Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocol.

Manaï M, van Middendorp H, Veldhuijzen DS, van der Pol JA, Huizinga TWJ, Evers AWM.

Trials. 2020 Jan 6;21(1):15. doi: 10.1186/s13063-019-3777-6.

6.

Immune contexture of cholangiocarcinoma.

Paillet J, Kroemer G, Pol JG.

Curr Opin Gastroenterol. 2020 Mar;36(2):70-76. doi: 10.1097/MOG.0000000000000613.

PMID:
31895228
7.

ECHO, the executable CHOndrocyte: A computational model to study articular chondrocytes in health and disease.

Schivo S, Khurana S, Govindaraj K, Scholma J, Kerkhofs J, Zhong L, Huang X, van de Pol J, Langerak R, van Wijnen AJ, Geris L, Karperien M, Post JN.

Cell Signal. 2019 Dec 11;68:109471. doi: 10.1016/j.cellsig.2019.109471. [Epub ahead of print]

8.

Photoefficient 2nd generation molecular motors responsive to visible light.

Pfeifer L, Scherübl M, Fellert M, Danowski W, Cheng J, Pol J, Feringa BL.

Chem Sci. 2019 Aug 9;10(38):8768-8773. doi: 10.1039/c9sc02150g. eCollection 2019 Oct 14.

9.

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.

Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, Boedec E, Gorwood P, Ramoz N, Clément K, Pelloux V, Rohia A, Pattou F, Raverdy V, Caiazzo R, Denis RGP, Boya P, Galluzzi L, Madeo F, Migrenne-Li S, Cruciani-Guglielmacci C, Tavernarakis N, López-Otín C, Magnan C, Kroemer G.

Cell Metab. 2019 Dec 3;30(6):1171. doi: 10.1016/j.cmet.2019.10.011. No abstract available.

PMID:
31801056
10.

Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients.

Boswijk E, Franssen R, Vijgen GHEJ, Wierts R, van der Pol JAJ, Mingels AMA, Cornips EMJ, Majoie MHJM, van Marken Lichtenbelt WD, Mottaghy FM, Wildberger JE, Bucerius J.

EJNMMI Res. 2019 Nov 27;9(1):101. doi: 10.1186/s13550-019-0567-9.

11.

A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice.

Lévesque S, Le Naour J, Pietrocola F, Paillet J, Kremer M, Castoldi F, Baracco EE, Wang Y, Vacchelli E, Stoll G, Jolly A, De La Grange P, Zitvogel L, Kroemer G, Pol JG.

Oncoimmunology. 2019 Sep 7;8(11):e1657375. doi: 10.1080/2162402X.2019.1657375. eCollection 2019.

12.

Effects of interleukin-2 in immunostimulation and immunosuppression.

Pol JG, Caudana P, Paillet J, Piaggio E, Kroemer G.

J Exp Med. 2020 Jan 6;217(1). pii: e20191247. doi: 10.1084/jem.20191247.

PMID:
31611250
13.

Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.

Pol JG, Bridle BW, Lichty BD.

Methods Mol Biol. 2020;2058:191-211. doi: 10.1007/978-1-4939-9794-7_12.

PMID:
31486039
14.

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.

Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, Boedec E, Gorwood P, Ramoz N, Clément K, Pelloux V, Rohia A, Pattou F, Raverdy V, Caiazzo R, Denis RGP, Boya P, Galluzzi L, Madeo F, Migrenne-Li S, Cruciani-Guglielmacci C, Tavernarakis N, López-Otín C, Magnan C, Kroemer G.

Cell Metab. 2019 Oct 1;30(4):754-767.e9. doi: 10.1016/j.cmet.2019.07.010. Epub 2019 Aug 15. Erratum in: Cell Metab. 2019 Dec 3;30(6):1171.

PMID:
31422903
15.

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer.

De Palma FDE, D'Argenio V, Pol J, Kroemer G, Maiuri MC, Salvatore F.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1017. doi: 10.3390/cancers11071017. Review.

16.

Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study.

Fuchs TA, Ziccardi S, Dwyer MG, Charvet LE, Bartnik A, Campbell R, Escobar J, Hojnacki D, Kolb C, Oship D, Pol J, Shaw MT, Wojcik C, Yasin F, Weinstock-Guttman B, Zivadinov R, Benedict RHB.

Mult Scler Relat Disord. 2019 Sep;34:103-111. doi: 10.1016/j.msard.2019.06.026. Epub 2019 Jun 22.

PMID:
31254960
17.

Tumor lysis with LTX-401 creates anticancer immunity.

Xie W, Mondragón L, Mauseth B, Wang Y, Pol J, Lévesque S, Zhou H, Yamazaki T, Eksteen JJ, Zitvogel L, Sveinbjørnsson B, Rekdal Ø, Kepp O, Kroemer G.

Oncoimmunology. 2019 Apr 13;8(7):1594555. doi: 10.1080/2162402X.2019.1594555. eCollection 2019.

PMID:
31143516
18.

Trial watch: dietary interventions for cancer therapy.

Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G.

Oncoimmunology. 2019 Apr 3;8(7):1591878. doi: 10.1080/2162402X.2019.1591878. eCollection 2019. Review.

19.

Balancing traditional activities and cognitive pharmaceutical services by community pharmacists: a work sampling study.

van de Pol J, Koster E, Hövels A, Bouvy M.

Int J Clin Pharm. 2019 Aug;41(4):872-879. doi: 10.1007/s11096-019-00852-0. Epub 2019 May 28.

20.
21.
22.

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer.

Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G.

Nat Commun. 2019 Apr 17;10(1):1883. doi: 10.1038/s41467-019-09838-y.

23.

Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate.

Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, Mondragón L, Kepp O, Galluzzi L, Martinou JC, Hess-Stumpp H, Ziegelbauer K, Kroemer G, Maiuri MC.

Cell Rep. 2019 Apr 16;27(3):820-834.e9. doi: 10.1016/j.celrep.2019.03.058.

24.

Epithelioid sarcoma of paratesticular region: A case report of an unusual case.

Pol JN, Nisar Z, Phadke MD, Kadkol GA.

Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):306-309. doi: 10.4103/IJPM.IJPM_431_18.

PMID:
30971563
25.

Crizotinib-induced immunogenic cell death in non-small cell lung cancer.

Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G.

Nat Commun. 2019 Apr 2;10(1):1486. doi: 10.1038/s41467-019-09415-3. Erratum in: Nat Commun. 2019 Apr 17;10(1):1883.

26.

Issue framing in online voting advice applications: The effect of left-wing and right-wing headers on reported attitudes.

Kamoen N, van de Pol J, Krouwel A, de Vreese C, Holleman B.

PLoS One. 2019 Feb 21;14(2):e0212555. doi: 10.1371/journal.pone.0212555. eCollection 2019. Erratum in: PLoS One. 2019 May 9;14(5):e0216969.

27.

Anticancer effects of anti-CD47 immunotherapy in vivo.

Iribarren K, Buque A, Mondragon L, Xie W, Lévesque S, Pol J, Zitvogel L, Kepp O, Kroemer G.

Oncoimmunology. 2018 Dec 11;8(3):1550619. doi: 10.1080/2162402X.2018.1550619. eCollection 2019.

28.

Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.

Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RH.

Mult Scler. 2020 Feb;26(2):245-252. doi: 10.1177/1352458518820272. Epub 2019 Jan 7.

PMID:
30615562
29.

Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study.

van de Pol JAA, van den Brandt PA, Schouten LJ.

Br J Cancer. 2019 Feb;120(3):368-374. doi: 10.1038/s41416-018-0356-7. Epub 2018 Dec 19.

30.

Human native endocarditis caused by Streptococcus canis-a case report.

Mališová B, Šantavý P, Lovečková Y, Hladký B, Kotásková I, Pol J, Lonský V, Němec P, Freiberger T.

APMIS. 2019 Jan;127(1):41-44. doi: 10.1111/apm.12905.

PMID:
30549135
31.

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.

Pol JG, Acuna SA, Yadollahi B, Tang N, Stephenson KB, Atherton MJ, Hanwell D, El-Warrak A, Goldstein A, Moloo B, Turner PV, Lopez R, LaFrance S, Evelegh C, Denisova G, Parsons R, Millar J, Stoll G, Martin CG, Pomoransky J, Breitbach CJ, Bramson JL, Bell JC, Wan Y, Stojdl DF, Lichty BD, McCart JA.

Oncoimmunology. 2018 Sep 19;8(1):e1512329. doi: 10.1080/2162402X.2018.1512329. eCollection 2019.

32.

Trial watch: Peptide-based vaccines in anticancer therapy.

Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2018 Sep 6;7(12):e1511506. doi: 10.1080/2162402X.2018.1511506. eCollection 2018. Review.

33.

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.

Pol JG, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, Clements DR, Fahrner JE, Fend L, Bell JC, Mossman KL, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2018 Aug 27;7(12):e1503032. doi: 10.1080/2162402X.2018.1503032. eCollection 2018. Review.

34.

Development and applications of oncolytic Maraba virus vaccines.

Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD.

Oncolytic Virother. 2018 Nov 26;7:117-128. doi: 10.2147/OV.S154494. eCollection 2018. Review.

35.

Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.

Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2020 Jan;26(1):109-113. doi: 10.1177/1352458518813287. Epub 2018 Nov 22.

PMID:
30465463
36.

Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models.

Humeau J, Lévesque S, Kroemer G, Pol JG.

Methods Mol Biol. 2019;1884:297-315. doi: 10.1007/978-1-4939-8885-3_21.

PMID:
30465212
37.

How community pharmacists prioritize cognitive pharmaceutical services.

van de Pol JM, Koster ES, Hövels AM, Bouvy ML.

Res Social Adm Pharm. 2019 Sep;15(9):1088-1094. doi: 10.1016/j.sapharm.2018.09.012. Epub 2018 Sep 26.

38.

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts.

Stoll G, Pol J, Soumelis V, Zitvogel L, Kroemer G.

Oncoimmunology. 2018 Aug 6;7(10):e1484980. doi: 10.1080/2162402X.2018.1484980. eCollection 2018.

39.

Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies.

Gujar S, Pol JG, Kroemer G.

Oncoimmunology. 2018 Mar 13;7(8):e1442169. doi: 10.1080/2162402X.2018.1442169. eCollection 2018.

40.

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants.

Nguyen A, Ho L, Workenhe ST, Chen L, Samson J, Walsh SR, Pol J, Bramson JL, Wan Y.

Cell Rep. 2018 Jul 17;24(3):642-654. doi: 10.1016/j.celrep.2018.06.040.

41.

Metabolic vulnerability of cisplatin-resistant cancers.

Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G.

EMBO J. 2018 Jul 13;37(14). pii: e98597. doi: 10.15252/embj.201798597. Epub 2018 Jun 6.

42.

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.

Cruickshank B, Giacomantonio M, Marcato P, McFarland S, Pol J, Gujar S.

Front Immunol. 2018 Apr 3;9:654. doi: 10.3389/fimmu.2018.00654. eCollection 2018. Review.

43.

Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacy.

Pol J, Kroemer G.

Cell Res. 2018 May;28(5):501-502. doi: 10.1038/s41422-018-0031-9. Epub 2018 Mar 28. No abstract available.

44.

Pharmacy in transition: A work sampling study of community pharmacists using smartphone technology.

van de Pol JM, Geljon JG, Belitser SV, Frederix GWJ, Hövels AM, Bouvy ML.

Res Social Adm Pharm. 2019 Jan;15(1):70-76. doi: 10.1016/j.sapharm.2018.03.004. Epub 2018 Mar 9.

45.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.

Loef M, Kroon FPB, Bergstra SA, van der Pol JA, Lems WF, Kerstens PJSM, Allaart CF, Kloppenburg M.

Rheumatology (Oxford). 2018 Nov 1;57(11):1917-1924. doi: 10.1093/rheumatology/key016.

PMID:
29471377
46.

Uncomplicated 90Y Selective Internal Radio Therapy in a Patient With Hepatocellular Carcinoma After Arterial and Portal Vein Embolizations.

van der Pol J, de Vos-Geelen J, Bucerius J, Mitea C, van der Leij C.

Clin Nucl Med. 2018 Mar;43(3):180-182. doi: 10.1097/RLU.0000000000001945.

PMID:
29389772
47.

Teachers' monitoring of students' text comprehension: can students' keywords and summaries improve teachers' judgment accuracy?

Engelen JAA, Camp G, van de Pol J, de Bruin ABH.

Metacogn Learn. 2018;13(3):287-307. doi: 10.1007/s11409-018-9187-4. Epub 2018 Dec 10.

48.

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.

Gujar S, Pol JG, Kim Y, Lee PW, Kroemer G.

Trends Immunol. 2018 Mar;39(3):209-221. doi: 10.1016/j.it.2017.11.006. Epub 2017 Dec 20. Review.

PMID:
29275092
49.

Trial watch: DNA-based vaccines for oncological indications.

Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L.

Oncoimmunology. 2017 Nov 20;6(12):e1398878. doi: 10.1080/2162402X.2017.1398878. eCollection 2017. Review.

50.

New Food Baits for Trapping German Cockroaches, Blattella germanica (L.) (Dictyoptera: Blattellidae).

Pol JC, Jimenez SI, Gries G.

J Econ Entomol. 2017 Dec 5;110(6):2518-2526. doi: 10.1093/jee/tox247.

PMID:
29029107

Supplemental Content

Support Center